Profile: Cipla Ltd (CIPL.NS)

CIPL.NS on National Stock Exchange of India

634.90INR
6:28am EDT
Change (% chg)

Rs19.50 (+3.17%)
Prev Close
Rs615.40
Open
Rs619.00
Day's High
Rs637.20
Day's Low
Rs616.75
Volume
1,789,439
Avg. Vol
1,896,680
52-wk High
Rs752.85
52-wk Low
Rs425.25

Search Stocks
Cipla Limited (Cipla) is an India-based global pharmaceutical company. The Company’s portfolio includes approximately 2000 products in 65 therapeutic categories with one quality standard globally. Cipla’s turnover in 2012/13 was approximately 1.5 billion USD. The Company’s research and development focus on developing products and drug delivery systems for different formulations. Africa contributes 25% of overall revenues, a testament to its focus on ensuring affordable access to patients across the world. As the Company that showed the way in manufacturing active pharmaceutical ingredients in India, Cipla has expanded its portfolio to approximately 200 products. The Company offers approximately 65 different inhaled products and has a range of inhaled medications and devices. Across markets, Cipla offers metered dose inhalers (pMDIs) with dose indicators, innovative dry powder inhalers, nasal sprays, nebulisers, non-electrostatic spacers, and infant and baby masks.

Company Address

Cipla Ltd

Mumbai Central
MUMBAI     400008
P: +9122.23082891
F: +9122.23070013

Company Web Links

Search Stocks